18 reports

  • DERMATOLOGY THERAPEUTICS MARKET, GLOBAL, LICENSING DEALS, 2006-2017 (PART 3)
  • DERMATOLOGY THERAPEUTICS MARKET, GLOBAL, LICENSING DEALS, 2006-2017 (PART 2)

DNX Biopharmaceuticals Inc.

  • Biopharmaceutical
  • Dermatology
  • Therapy
  • Biopharmaceuticals Inc.
  • Coherus BioSciences, Inc.
  • Keryx Biopharmaceuticals Inc, Subsidiaries
  • Keryx Biopharmaceuticals Inc, Key Competitors

GlobalData Keryx Biopharmaceuticals Inc, reported one pharmaceuticals & healthcare deal in YTD 2018.

  • Biopharmaceutical
  • Pharmaceutical
  • United States
  • Demand
  • Biopharmaceuticals Inc.
  • ALDER BIOPHARMACEUTICALS INC - KEY COMPETITORS
  • ALDER BIOPHARMACEUTICALS INC, KEY COMPETITORS

Deal History:Completed: On February ##, 2018, Alder Biopharma completed the public offering of ##. ##% convertible senior notes due February ##, 2025, for gross proceeds of USD## million.

  • Biopharmaceutical
  • Pain Relief
  • United States
  • Company
  • Biopharmaceuticals Inc.
  • Navidea Biopharmaceuticals Inc - Locations And Subsidiaries
  • Navidea Biopharmaceuticals Inc - Key Competitors

GlobalData Navidea Biopharmaceuticals Inc reported one medical equipment deal worth $## million in YTD 2018.

  • Biopharmaceutical
  • Medical Device
  • United States
  • Company
  • Biopharmaceuticals Inc.
  • Navidea Biopharmaceuticals Inc - Locations And Subsidiaries
  • Navidea Biopharmaceuticals Inc - Key Employees

GlobalData Navidea Biopharmaceuticals Inc reported one pharmaceuticals & healthcare deal worth $## million in YTD 2018.

  • Biopharmaceutical
  • Pharmaceutical
  • United States
  • Company
  • Biopharmaceuticals Inc.

Indian Journal of Ophthalmology; ##(##): ## Pfizer.

  • Biopharmaceutical
  • Pharmaceutical
  • Therapy
  • Clearside Biomedical, Inc.
  • Coherus BioSciences, Inc.
  • Transposagen Biopharmaceuticals Inc - Key Employees
  • Transposagen Biopharmaceuticals Inc - Locations And Subsidiaries

The Patent Trial and Appeal Board (PTAB) declined to institute review, finding that Aragen and Transposagen had " not shown a reasonable likelihood that it would prevail in showing the unpatentability of at least one challenged claimof the patents.

  • Biopharmaceutical
  • Medical Biotechnology
  • United States
  • Litigation And Patent
  • Biopharmaceuticals Inc.
  • Mycenax Biotech and Pfizer have the highest number of molecules in pipeline

You can easily book an appointment with one online.

  • Biopharmaceutical
  • Medical Biotechnology
  • Monoclonal Antibody
  • Coherus BioSciences, Inc.
  • Pfizer Inc.
  • PARTNERSHIP - DEAL REPORTS
  • CAPITAL RAISING - DEAL REPORTS

Company information: Partners Partner ##: Laureate Biopharmaceutical Services, Inc.

  • Biopharmaceutical
  • Medical Biotechnology
  • United States
  • Corporate Finance
  • Biopharmaceuticals Inc.

TS-## (tegafur, gimeracil, oteracil) ##.

  • Biopharmaceutical
  • North America
  • United States
  • Demand
  • Coherus BioSciences, Inc.
  • TOP DEALS IN (2012 -YTD2016)
  • PARTNERSHIP - DEAL REPORTS

Partner ## Partner ## Deal status Deal value (estimated) ($m) Deal category Deal sub-category Intendis GmBH Kythera Biopharmaceuticals, Inc.

  • Biopharmaceutical
  • Medical Biotechnology
  • United States
  • Corporate Finance
  • Biopharmaceuticals Inc.
  • DIVESTMENTS - DEAL REPORTS
  • CAPITAL RAISING - DEAL REPORTS

Other The asset includes investigational hemophilia compound OBI- ## and related assets of Inspiration Biopharmaceuticals, Inc., a biopharmaceutical company.

  • Biopharmaceutical
  • United States
  • Company Financials
  • Corporate Finance
  • Biopharmaceuticals Inc.
  • TOP DEALS IN (2012 -YTD2016)
  • PRIVATE EQUITY & OWNERSHIP

Deal in brief Partner ## Partner ## Deal status Deal value ($m) Deal category Deal sub-category Date of announcement Keryx Biopharmaceuticals, Inc.

  • Biopharmaceutical
  • Japan
  • United States
  • Corporate Finance
  • Biopharmaceuticals Inc.
  • DEAL REPORT: TRANSPOSAGEN BIOPHARMACEUTICALS SIGNS AGREEMENT WITH CHARLES RIVER LABORATORIES
  • DEAL REPORT: TRANSPOSAGEN BIOPHARMACEUTICALS SIGNS MARKETING AND DISTRIBUTION AGREEMENT WITH TACONIC

Partner ## Transposagen Biopharmaceuticals, Inc.

  • Biopharmaceutical
  • Medical Biotechnology
  • United States
  • Company
  • Biopharmaceuticals Inc.
  • CAPITAL RAISING - DEAL REPORTS

Deal in brief Target Acquirer ## Acquirer ## Deal status Deal value ($m) Deal category Deal sub-category Round of financing Date of completion Itero Biopharmaceuticals, Inc.

  • Biopharmaceutical
  • Medical Biotechnology
  • Pharmaceutical
  • Corporate Finance
  • Biopharmaceuticals Inc.
  • COHERUS BIOSCIENCES INC, KEY COMPETITORS
  • COHERUS BIOSCIENCES RAISES USD6.8 MILLION IN PRIVATE PLACEMENT OF SHARES

IT SERVES BIOPHARMACEUTICAL, PHARMACEUTICAL, BIOTECHNOLOGY, AND MEDICAL DEVICE COMPANIES IN NORTH AMERICA, EUROPE, AFRICA, ASIA PACIFIC, AND LATIN AMERICA.

  • Biopharmaceutical
  • Healthcare
  • Company
  • Corporate Finance
  • Coherus BioSciences, Inc.
  • FEBRILE NEUTROPENIA - PIPELINE BY COHERUS BIOSCIENCES, INC., H2 2016
  • COHERUS BIOSCIENCES, INC.

The molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Preclinical, Discovery and Unknown stages are ##, ##, ##, ##, ##, ## and ## respectively.

  • Biopharmaceutical
  • Biosimilar
  • Medical Biotechnology
  • Monoclonal Antibody
  • Coherus BioSciences, Inc.
  • POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS (PJIA) - PIPELINE BY COHERUS BIOSCIENCES INC, H2 2016
  • COHERUS BIOSCIENCES INC

On July ##, 2016, EPIRUS Biopharmaceuticals, Inc.

  • Biopharmaceutical
  • Biosimilar
  • Monoclonal Antibody
  • Musculoskeletal Disorder
  • Coherus BioSciences, Inc.